Connection

ABBAS RANA to United States

This is a "connection" page, showing publications ABBAS RANA has written about United States.
Connection Strength

1.023
  1. Trends in marginal lung allograft survival: Advanced-age donors improve. Clin Transplant. 2022 09; 36(9):e14777.
    View in: PubMed
    Score: 0.071
  2. Significant improvements, but consistent disparities in survival for African Americans after liver transplantation. Clin Transplant. 2022 06; 36(6):e14646.
    View in: PubMed
    Score: 0.069
  3. The impact of diabetes on young transplant recipients: An American perspective. Nephrology (Carlton). 2022 May; 27(5):450-457.
    View in: PubMed
    Score: 0.068
  4. Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
    View in: PubMed
    Score: 0.063
  5. Pediatric length-of-stay index following liver transplantation. Pediatr Transplant. 2020 11; 24(7):e13779.
    View in: PubMed
    Score: 0.062
  6. Outcomes in Solid-Organ Transplantation: Success and Stagnation. Tex Heart Inst J. 2019 02; 46(1):75-76.
    View in: PubMed
    Score: 0.055
  7. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.049
  8. Waiting list outcomes in pediatric lung transplantation: Poor results for children listed in adult transplant programs. J Heart Lung Transplant. 2017 Nov; 36(11):1201-1208.
    View in: PubMed
    Score: 0.049
  9. Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States. Pediatr Nephrol. 2017 04; 32(4):669-678.
    View in: PubMed
    Score: 0.047
  10. Veterans Administration Liver Transplant Programs Perform as Well as Their Affiliated Academic Institutions. Ann Surg. 2016 Aug; 264(2):239-40.
    View in: PubMed
    Score: 0.047
  11. Profiling immunologic risk for acute rejection in liver transplantation: Recipient age is an important risk factor. Transpl Immunol. 2016 09; 38:44-9.
    View in: PubMed
    Score: 0.046
  12. Pediatric Liver Transplant Center Volume and the Likelihood of Transplantation. Pediatrics. 2015 Jul; 136(1):e99-e107.
    View in: PubMed
    Score: 0.043
  13. Survival benefit of solid-organ transplant in the United States. JAMA Surg. 2015 Mar 01; 150(3):252-9.
    View in: PubMed
    Score: 0.042
  14. Geographic inequities in liver allograft supply and demand: does it affect patient outcomes? Transplantation. 2015 Mar; 99(3):515-20.
    View in: PubMed
    Score: 0.042
  15. Geographic inequity results in disparate mortality: a multivariate intent-to-treat analysis of liver transplant data. Clin Transplant. 2015 Jun; 29(6):484-91.
    View in: PubMed
    Score: 0.042
  16. The combined organ effect: protection against rejection? Ann Surg. 2008 Nov; 248(5):871-9.
    View in: PubMed
    Score: 0.027
  17. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
    View in: PubMed
    Score: 0.019
  18. Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver Transpl. 2023 01 01; 29(1):15-25.
    View in: PubMed
    Score: 0.018
  19. Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA. Hepatology. 2021 12; 74(6):3316-3329.
    View in: PubMed
    Score: 0.017
  20. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transpl. 2021 05; 27(5):684-698.
    View in: PubMed
    Score: 0.016
  21. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 12; 72(6):2014-2028.
    View in: PubMed
    Score: 0.016
  22. Survey of public attitudes towards imminent death donation in the United States. Am J Transplant. 2021 01; 21(1):114-122.
    View in: PubMed
    Score: 0.015
  23. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433.
    View in: PubMed
    Score: 0.015
  24. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg. 2020 04; 271(4):616-624.
    View in: PubMed
    Score: 0.015
  25. Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
    View in: PubMed
    Score: 0.014
  26. Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States. Am J Transplant. 2018 06; 18(6):1494-1501.
    View in: PubMed
    Score: 0.013
  27. Trends in pediatric liver transplant donors and deceased donor circumstance of death in the United States, 2002-2015. Pediatr Transplant. 2018 05; 22(3):e13156.
    View in: PubMed
    Score: 0.013
  28. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists. Clin Gastroenterol Hepatol. 2018 02; 16(2):278-287.e7.
    View in: PubMed
    Score: 0.013
  29. Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology. 2014 Dec; 60(6):1957-62.
    View in: PubMed
    Score: 0.010
  30. Pretransplantation patient characteristics and survival following combined heart and kidney transplantation: an analysis of the United Network for Organ Sharing Database. Arch Surg. 2009 Mar; 144(3):241-6.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.